Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies von Collins, M., Michot, J.M., Danlos, F.X., Mussini, C., Soularue, E., Mateus, C., Loirat, D., Buisson, A., Rosa, I., Lambotte, O., Laghouati, S., Chaput, N., Coutzac, C., Voisin, A.L., Soria, J.C., Marabelle, A., Champiat, S., Robert, C., Carbonnel, F.

Volltext

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance von Loriot, Y., Marabelle, A., Guégan, J.P., Danlos, F.X., Besse, B., Chaput, N., Massard, C., Planchard, D., Robert, C., Even, C., Khettab, M., Tselikas, L., Friboulet, L., André, F., Nafia, I., Le Loarer, F., Soria, J.C., Bessede, A., Italiano, A.

Volltext

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients von Bessede, A., Marabelle, A., Guégan, J.P., Danlos, F.X., Cousin, S., Peyraud, F., Chaput, N., Spalato, M., Roubaud, G., Cabart, M., Khettab, M., Chaibi, A., Rey, C., Nafia, I., Mahon, F.X., Soria, J.C., Italiano, A.

Volltext

High levels of TNFα in patients with COVID-19 refractory to tocilizumab von Danlos, F.X., Ackermann, F., Rohmer, J., Roumier, M., Marabelle, A., Michot, J.M.

Volltext

P1.22-20 High Incidence of Ischemic Stroke in Patients with Non-small cell lung cancer and RET fusions von Aldea, M., Marinello, A., Guyon, D., Gazzah, A., Bihoreau, J., Smaali, S., Danlos, F.X., Laparra, A., Ciuffini, L.A., Grecea, M., Abdayem, P., Frelaut, M., Lavaud, P., Remon Masip, J., Barlesi, F., Planchard, D., Besse, B.

Volltext

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials? von Laparra, A., Kfoury, M., Champiat, S., Danlos, F.X., Martin-Romano, P., Simonaggio, A., Baldini, C., Vuagnat, P., Mateus, C., Voisin, A.L., Albiges, L., Besse, B., Even, C., Robert, C., Laghouati, S., Massard, C., Marabelle, A., Lambotte, O., Michot, J.M.

Volltext

Clonal Hematopoiesis of indeterminate potential in patients with advanced NSCLC treated with ICB von Rodriguez, J.E., Danlos, F.X., Larive, A., Marabelle, A., Frelaut, M., Tagliamento, M., Aldea, M., Besse, B., Micol, J.B., Marzac, C., Chaput-Gras, N., Massard, C., Baldini, C.

Volltext

Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy von Pradere, P., Michot, J.M., Champiat, S., Danlos, F.X., Marabelle, A., Lambotte, O., Albiges, L., Le Pavec, J.

Volltext

Allergic broncho-pulmonary aspergillosis following treatment with an anti-program death 1 monoclonal antibody therapy von Pradere, P, Michot, J.M, Champiat, S, Danlos, F.X, Marabelle, A, Lambotte, O, Albiges, L, Le Pavec, J

Volltext

Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy von Baldini, C., Martin-Romano, P., Voisin, A.-L., Danlos, F.X., Champiat, S., Laghouati, S., Kfouri, M., Vincent, H., Nagera, C., Postel-Vinay, S., Varga, A., Ribrag, V., Besse, B., Hollebecque, A., Lambotte, O., Michot, J.-M., Soria, J.-C., Massard, C., Marabelle, A.

Volltext

SIOG2022-0154 - Use of the Geriatric Core Dataset for older patients included in early phase trials von Seknazi, L., Goldschmidt, V., Champiat, S., Hollebecque, A., Martin-Romano, P., Bahleda, R., Gazzah, A., Michot, J.M., Sarkozy, C., Vuagnat, P., Ouali, K., Bayle, A., Danlos, F.X., Mahjoubi, L., Massard, C., Ponce Aix, S., Paillaud, E., Baldini, C.

Volltext

Use of the Geriatric Core Dataset for older patients included in early phase trials von Seknazi, L., Goldschmidt, V., Champiat, S., Hollebecque, A., Martin-Romano, P., Bahleda, R., Gazzah, A., Michot, J.M., Sarkozy, C., Vuagnat, P., Ouali, K., Bayle, A., Danlos, F.X., Mahjoubi, L., Massard, C., Ponce Aix, S., Paillaud, E., Baldini, C.

Volltext

Incidence of adverse events in older patients treated with Chemotherapy+Immunotherapy combinations von Rached, L., Laparra, A., Aldea, M., Frelaut, M., Besse, B., Planchard, D., Viansone, A., Larive, A., Danlos, F.X., Goldschmidt, V., Beraud-Chaulet, G., Lazarovici-Nagera, C., Ap-Thomas, Z., Marabelle, A., Champiat, S., Mourato-Ribeiro, J., Even, C., Aix, S. Ponce, Baldini, C.

Volltext

Safety and efficacy of antibody drug conjugates in older patients with solid tumors von Vaz Ferreira, A., Frelaut, M., Pagès, A., Hollebecque, A., Gazzah, A., Bahleda, R., Michot, J.M., Danlos, F.X., Seknazi, L., Goldschmidt, V., Hénon, C., Sakkal, M., Smolenschi, C., Champiat, S., Marabelle, A., Loriot, Y., Lazarovici-Nagera, C., Ap-Thomas, Z., Chaullet, G. Beraud, Ouali, K., Delaye, M., Aix, S. Ponce, Baldini, C.

Volltext

High prevalence of Clonal Hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors von Rodriguez, J.E., Bayle, A., Pages, A., Danlos, F.X., Goldschmidt, V., Seknazi, L., Vuagnat, P., Martin Romano, P., Hollebecque, A., Smolenschi, C., Mahjoubi, L., Gazzah, A., Bahleda, R., Sarkozy, C., Ouali, K., Loriot, Y., Marzac, C., Ponce, S., Italiano, A., Micol, J.B., Baldini, C.

Volltext

SIOG2022-0098 - High prevalence of Clonal Hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors von Rodriguez, J.E., Bayle, A., Pages, A., Danlos, F.X., Goldschmidt, V., Seknazi, L., Vuagnat, P., Martin Romano, P., Hollebecque, A., Smolenschi, C., Mahjoubi, L., Gazzah, A., Bahleda, R., Sarkozy, C., Ouali, K., Loriot, Y., Marzac, C., Ponce, S., Italiano, A., Micol, J.B., Baldini, C.

Volltext

Points à considérer de l’EULAR sur l’initiation ou la reprise d’un traitement ciblé chez un patient atteint de rhumatisme inflammatoire chronique ayant un antécédent de cancer... von Sebbag, E., Lauper, K., Molina-Collada, J., Aletaha, D., Askling, J., Benesova, K., Bertheussen, H., Bitoun, S., Bolek, E.C., Burmester, G.R., Canhão, H., Chatzidionysiou, K., Curtis, J., Danlos, F.X., Guimaraes, V., Hetland, M., Iannone, F., Kostine, M., Wenzel Kragstrup, T., Kvien, T.K., Regierer, A., Schulze-Koops, H., Silva-Fernández, L., Zoltán, S., Buch, M., Finckh, A., Gottenberg, J.E.

Volltext

Au-delà du grade maximum de toxicité : la multi-toxicité comme un nouveau marqueur pour évaluer la tolérance des anti-PD-1 ou anti-PD-L1 von Laparra, A., Danlos, F.X., Voisin, A.L., Mateus, C., Champiat, S., Simonaggio, A., Lallart, A., Lambotte, O., Michot, J.M.

Volltext

Tolérance et efficacité des anticorps anti immune check-point inhibiteurs (anti PD-1/PD-L1) chez les patients atteints d’une maladie auto-immune ou inflammatoire von Danlos, F.X., Voisin, A.L., Dyevre, V., Michot, J.M., Routier, E., Champiat, S., Massard, C., Besse, B., Mateus, C., Lanoy, E., Marabelle, A., Lambotte, O.

Volltext

Une première observation de périartérite rénale typique associée à une polyglobulie secondaire compliquant une maladie associée aux IgG4 (IgG4-RD) von Danlos, F.X., Daoued, F., Rohmer, J., Cluzel, G., François, H., Lazure, T., Seror, R., Mariette, X.

Volltext